« Back
Home /
Ondansetron (hydrochloride dihydrate)

Ondansetron (hydrochloride dihydrate)

Item no.	HY-B0002A-100mg
Manufacturer	MedChem Express
CASRN	103639-04-9
Amount	100 mg
Quantity options	100 mg 10 mMx1 mL 1 g 50 mg 5 g
Category	Metabolism Regulation of Appetite Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Clone	N/A
Specific against	other
Purity	99.94
Formula	C18H24ClN3O3
Citations	Eur J Pharm Sci. 2023 May 22;106475. Int J Pharm. 2015 Dec 30;496(1):33-41. Patent. US20170319486A1. Front Pharmacol. 2024 Aug 21:15:1443169. J Ethnopharmacol. 2024 Jan 5:117703. Journal of Radiation Research and Applied Sciences. 2023 Dec, 16(4), 100682. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Nov 30;110689. SSRN. 2023 Srep 5. [1]Yamamoto K, et al. Ondansetron, dexamethasone and an NK1 antagonist block radiation sickness in mice. Pharmacol Biochem Behav. 2005 Sep;82(1):24-9. [2]Wilde MI, et al. Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications. Drugs. 1996 Nov;52(5):773-94.
Smiles	O=C1C(CN2C=CN=C2C)CCC(N3C)=C1C4=C3C=CC=C4.[H]Cl.O.O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	GR 38032 (hydrochloride dihydrate); SN 307 (hydrochloride dihydrate)
Shipping condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	Neuroscience-Neuromodulation
Manufacturer - Targets	5-HT Receptor
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, sealed storage, away from moisture and light)
Molecular Weight	365.85
Product Description	Ondansetron (GR 38032) hydrochloride dehydrate is an orally active, highly selective and competitive 5-HT3 receptor antagonist (crosses the blood-brain barrier). Ondansetron hydrochloride dehydrate can be used in studies of preventing nausea and vomiting associated with cancer chemotherapy, radiation therapy and surgery[1][2].
Manufacturer - Research Area	Neurological Disease; Cancer
Solubility	DMSO : 100 mg/mL (ultrasonic)\|H2O : 16.67 mg/mL (ultrasonic)
Manufacturer - Pathway	GPCR/G Protein; Neuronal Signaling
Isoform	lactoferrin
Clinical information	Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-B0002A-100mg-safety-datasheet.pdf